Avammune Therapeutics

Philadelphia, United States

Avammune Therapeutics is a drug discovery company.

$12.0M raised

May 2025

Series A

Biotechnology Therapeutics

Top Investors

IvyCap VenturesShastra VCKotak Alternate Asset Managers1CrowdThe Chennai Angels

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avammune Therapeutics

How much funding has Avammune Therapeutics raised?

Avammune Therapeutics has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.

Who are Avammune Therapeutics's investors?

Avammune Therapeutics's investors include IvyCap Ventures, Shastra VC, Kotak Alternate Asset Managers, 1Crowd, The Chennai Angels.

Where is Avammune Therapeutics headquartered?

Avammune Therapeutics is headquartered in Philadelphia, United States.

What does Avammune Therapeutics do?

Avammune Therapeutics is a drug discovery company.

What stage is Avammune Therapeutics at?

Avammune Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 7, 2025.

MLA

"Avammune Therapeutics — Funding & Investors." VCBacked, May 7, 2025, https://www.vcbacked.co/company/avammune-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2025). Avammune Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/avammune-therapeutics

Wikipedia (cite web)

{{cite web |title=Avammune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avammune-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 7, 2025.

Similar Companies in Biotechnology